Updated:
Apixio Payment Integrity
Apixio Payment Integrity combines AI claims analytics with Rawlings' legal recovery and Varis' capital to pursue healthcare reimbursement recoveries.
Apixio Payment Integrity
Apixio Payment Integrity/The Rawlings Company LLC/Varis LLC operates as a coordinated investment and services platform targeting payment integrity and cost containment in the US healthcare system. Apixio brings the AI-driven claims analytics, Rawlings supplies the legal recovery and subrogation infrastructure, and Varis serves as the financial engine, likely providing litigation funding or structured capital to scale recoveries. The group focuses on identifying improper payments across Medicare Advantage, commercial, and Medicaid managed-care plans. Its economics are tied directly to recoveries rather than management fees, creating a performance-contingent revenue profile. Active investment is concentrated in healthcare payment integrity, a niche that combines claims auditing, data science, and legal recovery. Asset classes include litigation finance, specialty finance, and revenue-cycle management equity. The platform covers the full lifecycle from identification through pursuit — transaction sizes typically vary by recovery complexity. Operations span the United States, with activity concentrated in major payer markets including New York, Florida, Texas, and California. Deployment flows into funding audits, carrying the cost of litigation, and occasionally acquiring distressed provider claims portfolios. The platform's scale and headcount are not publicly disclosed, operating through a distributed but integrated model with the Rawlings Company historically based in Kentucky. A dated operational highlight: in December 2023, Apixio was reportedly integrating its AI audit suite with Rawlings' recovery arm to accelerate subrogation timelines. No adjacent philanthropic vehicles or club memberships are publicly associated with the group. This structure separates it from standard private equity healthcare roll-ups. Rather than buying companies to improve operations, the tri-party arrangement fuses a technology company, a law firm-adjacent recovery business, and a funding vehicle into a single economic alignment. Governance and succession details remain opaque, but the operating logic — technology identifies the value, operations extract it, capital underwrites the process — functions as a closed-loop investment thesis.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
What is the relationship between Apixio, The Rawlings Company, and Varis LLC?
The three entities function as a coordinated platform for healthcare payment integrity. Apixio provides the data analytics and AI that identify improper claims payments. The Rawlings Company supplies the legal and operational infrastructure to recover those funds through subrogation and audit-driven demands. Varis LLC serves a financial role, likely providing the litigation funding or structured capital needed to pursue large-scale recoveries on a contingency basis.
How does the group generate investment returns?
Returns are predominantly contingency-based, not fee-driven. The group invests capital in auditing claims portfolios and funding recovery litigation or settlement negotiations. It then collects a negotiated percentage of any recoveries secured for its insurance and health-plan clients. This aligns economics directly with outcomes. Revenue streams likely include recovery shares, litigation finance yields, and potentially servicing fees for ongoing audit programs, though specific return structures are not publicly broken out.
What sectors does the group explicitly avoid?
The group's model is narrowly focused on post-payment healthcare claims. It avoids provider-facing revenue cycle management for hospitals, direct clinical care delivery, and life sciences investing. The platform also does not operate as a generalist litigation funder — its capital deployments remain specific to healthcare payer recoveries. There is no known activity in real assets, traditional private equity buyouts, or venture capital.
What is the group's known posture on co-investments?
The tri-party structure itself functions as a de facto internal co-investment model, with each entity contributing a distinct capability or capital type to each recovery pursuit. Whether the group opens specific recovery pools to external institutional co-investors is not publicly documented. The contingency-fee economics may reduce the need for outside equity, as recoveries can fund the next cycle of audits.
How does the group source its deal flow?
Proprietary deal flow originates from data. Apixio's algorithms analyze large-scale health plan claims data under contractual relationships with payers. The technology surfaces overpayments, coding errors, and subrogation opportunities that are invisible to conventional manual review. This algorithm-first sourcing provides an information asymmetry — the platform identifies recoverable value before formal disputes or collections processes begin.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: